about
Upregulation of UCP2 by adiponectin: the involvement of mitochondrial superoxide and hnRNP KInhibitory effects of Japanese herbal medicines sho-saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in micePrevalence of fatty liver disease and the economy in China: A systematic reviewRelationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidationA Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease.Prevalence of fatty liver disease and its risk factors in the population of South China.Is there any progress in the treatment of non-alcoholic fatty liver disease?Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-κB stress pathway.Immunological response in alcoholic liver disease.Relevance of low testosterone to non-alcoholic fatty liver diseaseRelationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.Metabolic syndrome in drug abuse.Nonalcoholic fatty liver disease and mitochondrial dysfunction.Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.Non alcoholic fatty liver disease in southern Iran: a population based study.Non-alcoholic steatohepatitis with normal aminotransferase values.Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.Nonalcoholic fatty liver disease among HIV-infected persons.Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis.Roles of alcohol drinking pattern in fatty liver in Japanese women.Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis.Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone.Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease.Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men.
P2860
Q28480923-F292F867-D80D-4802-9156-0B13C0537389Q28539042-7BF78519-E666-49E0-B73A-789EC2F0E417Q28647695-F288C148-1CA2-4B67-ACFF-A84E349B7C33Q33719929-524B92F0-6F0B-4BEB-9496-20B59CFF6387Q33767500-1F72EAF3-AEB1-4430-AE53-A0DA5B587806Q33858409-F4C63E0F-DD00-4D59-B61E-42570437D1E9Q34301287-B7C44E8F-AB27-4DB3-B084-538905A096C2Q34382961-9CB1D13E-31B8-4CBC-B863-1B0CF8149413Q34962813-8A6F7C78-036C-4C12-8E40-B4B3B858A769Q35404775-11F694C0-2BFE-4090-B4C7-E544D1EDA826Q35615727-A4C9D5DA-19AE-4AEB-94D0-7460B3CC906CQ36079305-DCBEC83F-8FBD-417E-B14B-5B50FC3362FEQ36800964-E3EAF187-806C-40A4-8D77-826A168A4E36Q37031208-78858D77-29D7-4434-B4CF-0447034FF1E9Q37054354-563EE38C-5750-4B76-9DEB-2FE98F344DBAQ37066731-9F4E8906-5EF3-4836-85C3-D0BB9899C3A5Q37073854-5A39AB85-F6F2-4359-BA1B-DC0D952AC40CQ37161620-3D63A3C9-698B-4F05-A933-8DA27EAAC677Q37228658-984DD8BB-E989-467A-9667-30342027C2F1Q37434578-1CD53F15-15A6-43C6-B98E-8B60DBF823B4Q37494299-19735B9F-9C76-41A2-A4C5-AD7F7253905BQ40164782-6100F6C7-0578-4F92-90CC-A57E148796DAQ40706947-2119104C-4927-4BE7-B9C8-ACEE3D644CA2Q42685890-9A8BDD91-52CD-4322-A739-25698F7DBB09Q42702473-7D90567E-FF8E-4554-BF08-B9D14365324CQ43174499-EA0317F1-7277-461C-AA10-616308C0B53AQ45224333-9F50D135-51BB-4ACC-B228-CED3DE20FAF9Q45928111-BD743507-28EB-4BAE-B43E-3557AB9E6261Q45974435-89C2F72C-42CD-427C-AB5D-92243C8B7AAEQ46117635-457B0D32-92F5-4E9A-9350-84D543B6D908
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Non-alcoholic steatohepatitis and metabolic syndrome.
@ast
Non-alcoholic steatohepatitis and metabolic syndrome.
@en
type
label
Non-alcoholic steatohepatitis and metabolic syndrome.
@ast
Non-alcoholic steatohepatitis and metabolic syndrome.
@en
prefLabel
Non-alcoholic steatohepatitis and metabolic syndrome.
@ast
Non-alcoholic steatohepatitis and metabolic syndrome.
@en
P1476
Non-alcoholic steatohepatitis and metabolic syndrome.
@en
P2093
Helena Cortez-Pinto
Mariana Machado
P304
P356
10.1097/01.MCO.0000241677.40170.17
P577
2006-09-01T00:00:00Z